Consistently, we showed that, if given sufficient amount in the colorectal cancer model, the vaccine may release GM-CSF and IL-2 in a good timing and effectively elicited an autologous T cells response, which achieved high efficacy in preventing from the tumor formation. Here, IL2 is linked to colorectal cancer.